Tuberculosis associated immune reconstitution inflammatory syndrome

Indian Journal of Tuberculosis

Volumn 57, Issue 4, 2010, Pages 177-179

  Sinha, Sanjeev ^a   Sharma, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT;

CD4 LYMPHOCYTE COUNT; DISEASE EXACERBATION; DRUG EFFICACY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INFECTION RISK; MEMORY CELL; RISK FACTOR; RISK REDUCTION; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; COMORBIDITY; MICROBIOLOGY;

ANTI-RETROVIRAL AGENTS; COMORBIDITY; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; TUBERCULOSIS;

EID: 79952114901     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. Corbett EL, Marston B, Churchyard GJ, et al. Tuberculosis in sub-Saharan Africa: opportunities, challenges and change in the era of antiretroviral treatment. Lancet 2006; 367(9514): 926-37.
2. Girardi E, Antonucci G Vanacore P, et al. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur Respir J 2004; 24(1): 11-7.
3. Lawn SD, Myer L, Bekker LG, et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: Impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20(12): 1605-12.
4. Lederman MM. Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS 2001; 15(Suppl2):S11-5.
5. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009; 48:101-7.
6. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8(8):516-23.
7. Cheng VC, Yam WC, Woo PC, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22(10):597-602.
8. Narita M, Ashkin D, Hollender ES, et al. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158(1): 157-61.
9. Breen RA, Smith CJ, Bettinson H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 2004; 59(8): 704-7.
10. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39(11): 1709-12.
11. Kumarasamy N, Chaguturu S, Mayer KH, et al. Incidence of immune reconstitution syndrome in HIV/tuberculosiscoinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr 2004; 37(5): 1574-6.
12. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005; 19(4): 399-406.
13. Michailidis C, Pozniak AL, Mandalia S, et al. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther 2005; 10(3): 417-22.
14. Manosuthi W, Kiertiburanakul S, Phoorisri T, et al. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect 2006; 53(6):357-63.
15. Lawn SD, Myer L, Bekker LG, et al. Tuberculosis associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21(3):335-41.
16. Burman W, Weis S, Vernon A, et al. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis Int J Tuberc Lung Dis 2007; 11(12): 1282-9.
17. Fishman JE, Saraf-Lavi E, Narita M, et al. Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy. Am J Roentgenol. 2000; 174(1):43-9.
18. Sharma SK, Dhooria S, Barwad P, et al. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition. Indian J Med Res 2010: 804-8.
19. Karmakar S, Sharma SK, Vashishtha R, et al. Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART. Clin Dev Immunol (in press).
20. Lawn SD, Wilkinson RJ, Lipman MC, et al. Immune reconstitution and unmasking of tuberculosis during antiretroviral ltherapy. Am J Respir Crit Care Med 2008; 177(7): 680-5.
21. Beom PW, Gyun CP; Hyun JJ, et al. Research Letters: Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART. AIDS 2007; 21(7): 875-7.